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Background
Arterial hypertension produces ventricular dilation, CSF
protein composition variations as well as alterations in
the circumventricular organ and choroid plexus (CP). Cer-
ebrospinal fluid (CSF) has an important relationship with
the blood and the brain, and encephalic pathology could
alter the connections between the blood, brain and CSF,
and consequently the protein composition of the CSF.
Furthermore, certain proteins could be used as markers
such as transthyretin and S-100β, which are extravasated
when central nervous system (CNS) barriers are breached.
The S-100β is primarily synthesized in the brain by the
astrocytes and is released into the blood when the blood
brain barrier (BBB) is disrupted. Transthyretin is a protein
primarily located in the brain in choroid plexus (CP), sub-
commissural organ (SCO) and, as soluble monomer, in
the CSF, where it has a positive gradient for extravasation
in peripheral blood, when the blood to CSF barrier (BCB)
is altered. The aim of the present work is to analyze the
CNS barriers in the arterial hypertension using antibodies
against S-100β, transthyretin monomer (TTRm), TA-p73
and Reissner fibre (AFRU).
Materials and methods
Brain, cerebrospinal fluid and serum were extracted from
control Wistar-Kioto (WKY) rats and spontaneously
hypertensive rats (SHR) of 10 months of age. Brain sec-
tions containing the SCO and the CP were processed by
immunohistochemistry using the following as primary
antibodies: anti-S-100β, anti-TTRm anti-TA-p73 and
AFRU. Western blot and 2-D electrophoresis of CSF,
serum and extracts of SCO and CP were performed.
Results
We have observed that the expression different antibodies
varied with the hypertension, thus TTRm in control rats
was clearly observed in the CP and scarcely observed in
the SCO, but the TTRm in SHR increased in the CP and is
clearly positive in the SCO. In both groups only the S-
100β – was present in the CP. TAp73-ir was lower in the
SCO and CP of SHR with respect to WKY rats and AFRU-
ir was also lower in SHR rats. Transthyretin was higher in
serum in the SHR with respect to WKY rats. However, in
the CSF the transthyretin was lower in the SHR compared
to WKY rats and contrarily S-100β was higher SHR com-
pared to WKY rats.
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Hypertension in these rats produces an increase of tran-
sthyretin in serum and a decrease in cerebrospinal fluid;
we conclude that hypertension could produce a disrup-
tion in the blood to CSF barrier that allows extravasation
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